Red Flags Detected

  • Departure Of Cfo (new) — The Board determined the CFO would no longer serve, with no disclosed reason for the departure.
NASDAQ: TNGX Tango Therapeutics, Inc. 8-K

Tango Therapeutics CFO Daniella Beckman departs; Matthew Gall appointed new CFO

Filed April 15, 2026 · Period ending April 10, 2026 · ~1 min read

4 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade TNGX commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 5, 2026 5:11 PM